Qi Ding

2.9k total citations
96 papers, 2.1k citations indexed

About

Qi Ding is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qi Ding has authored 96 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 18 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qi Ding's work include DNA Repair Mechanisms (7 papers), Cancer-related molecular mechanisms research (7 papers) and Genetics and Neurodevelopmental Disorders (6 papers). Qi Ding is often cited by papers focused on DNA Repair Mechanisms (7 papers), Cancer-related molecular mechanisms research (7 papers) and Genetics and Neurodevelopmental Disorders (6 papers). Qi Ding collaborates with scholars based in China, United States and Canada. Qi Ding's co-authors include Katheryn Meek, Susan P. Lees‐Miller, Pauline Douglas, Hongbing Wang, Dale A. Ramsden, Yeturu V.R. Reddy, Wei Wang, Xiaoping Cui, Zhuoyou Chen and Ruiqiong Ye and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Qi Ding

89 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Ding China 24 1.4k 510 467 196 189 96 2.1k
Edward Kim United States 27 1.6k 1.1× 536 1.1× 685 1.5× 391 2.0× 124 0.7× 47 2.5k
Eryk Kropiwnicki United States 8 1.4k 1.0× 281 0.6× 395 0.8× 193 1.0× 408 2.2× 10 2.4k
Dominique Joubert France 29 1.4k 1.0× 443 0.9× 353 0.8× 300 1.5× 119 0.6× 68 2.4k
Jian‐Ying Chuang Taiwan 28 1.6k 1.1× 435 0.9× 487 1.0× 104 0.5× 200 1.1× 84 2.3k
Tsung‐I Hsu Taiwan 28 1.4k 1.0× 459 0.9× 605 1.3× 129 0.7× 191 1.0× 87 2.4k
Ning Guo China 24 944 0.7× 642 1.3× 493 1.1× 83 0.4× 223 1.2× 85 2.0k
Zhuorui Xie United States 10 1.2k 0.8× 231 0.5× 338 0.7× 161 0.8× 308 1.6× 18 2.0k
Gigliola Sica Italy 26 866 0.6× 479 0.9× 403 0.9× 197 1.0× 281 1.5× 71 2.3k
Honghong Zhang China 22 751 0.5× 488 1.0× 262 0.6× 130 0.7× 262 1.4× 79 1.7k
Xiaolong Zhang China 22 1.1k 0.8× 272 0.5× 349 0.7× 102 0.5× 232 1.2× 70 1.8k

Countries citing papers authored by Qi Ding

Since Specialization
Citations

This map shows the geographic impact of Qi Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Ding more than expected).

Fields of papers citing papers by Qi Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Ding. The network helps show where Qi Ding may publish in the future.

Co-authorship network of co-authors of Qi Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Ding. A scholar is included among the top collaborators of Qi Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Ding. Qi Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yating, Ke Wen, Qi Ding, et al.. (2025). Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia/reperfusion injury. Signal Transduction and Targeted Therapy. 10(1). 150–150. 1 indexed citations
2.
Ding, Qi, et al.. (2024). Potassium sodium hydrogen citrate intervention on gut microbiota and clinical features in uric acid stone patients. Applied Microbiology and Biotechnology. 108(1). 51–51. 10 indexed citations
3.
Wang, Lingfang, Ke Wen, Yating Zhang, et al.. (2024). CD38 deficiency prevents diabetic nephropathy by inhibiting lipid accumulation and oxidative stress through activation of the SIRT3 pathway. Biochemistry and Cell Biology. 103. 1–12. 1 indexed citations
5.
Ding, Peng, Wenhui Cao, Qi Ding, et al.. (2023). A quantitative analysis on the rheological characteristics of polyurea thickeners with the geometry of helical fiber and nanotube. Journal of Industrial and Engineering Chemistry. 124. 232–239. 9 indexed citations
6.
Ren, Xiaoqiang, et al.. (2023). Physiological and clinical variables identify ARDS classes and therapeutic heterogeneity to glucocorticoids: a retrospective study. BMC Pulmonary Medicine. 23(1). 92–92. 4 indexed citations
7.
Ding, Qi, et al.. (2023). Concordance of adenosine deaminase with immunoglobulins and lymphocyte subsets in EBV-related diseases. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 49(1). 49–49. 4 indexed citations
9.
Chen, Lin, Yanguo Li, Yaqin Lu, et al.. (2022). Single-cell discovery of the scene and potential immunotherapeutic target in hypopharyngeal tumor environment. Cancer Gene Therapy. 30(3). 462–471. 5 indexed citations
10.
Jones, Alex L., Sunčica Zdravković, Craig Thorley, et al.. (2021). Do individual differences in face recognition ability moderate the other ethnicity effect?. Journal of Experimental Psychology Human Perception & Performance. 47(7). 893–907. 8 indexed citations
11.
Ding, Qi, Xueting Wu, Xuan Li, & Hongbing Wang. (2021). Vorinostat Corrects Cognitive and Non-Cognitive Symptoms in a Mouse Model of Fragile X Syndrome. The International Journal of Neuropsychopharmacology. 25(2). 147–159. 5 indexed citations
12.
Xu, Yanan, et al.. (2020). CircAP2A2 acts as a ceRNA to participate in infantile hemangiomas progression by sponging miR‐382‐5p via regulating the expression of VEGFA. Journal of Clinical Laboratory Analysis. 34(7). e23258–e23258. 16 indexed citations
13.
Ding, Qi, Xueting Wu, Zhuang Miao, et al.. (2020). Transcriptome signature analysis repurposes trifluoperazine for the treatment of fragile X syndrome in mouse model. Communications Biology. 3(1). 127–127. 13 indexed citations
14.
Dong, Shanshan, Ranran Wang, Hui Wang, et al.. (2019). HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3. Journal of Experimental & Clinical Cancer Research. 38(1). 110–110. 89 indexed citations
15.
Zhou, Xianju, et al.. (2013). Involvement of the GluN2A and GluN2B Subunits in Synaptic and Extrasynaptic N-methyl-d-aspartate Receptor Function and Neuronal Excitotoxicity. Journal of Biological Chemistry. 288(33). 24151–24159. 110 indexed citations
16.
Qiu, Xusheng, Song Zhou, Ming-liang Ji, et al.. (2012). Mutation Analysis of MESP2, HES7 and DUSP6 Gene Exons in Patients with Congenital Scoliosis. Studies in health technology and informatics. 176. 52–5. 2 indexed citations
17.
Chen, Jiawei, Yi‐Long Wu, Pengfei Shao, et al.. (2011). Association Between VHL Single Nucleotide Polymorphism (rs779805) and the Susceptibility to Prostate Cancer in Chinese. DNA and Cell Biology. 31(5). 790–796. 7 indexed citations
18.
Meek, Katheryn, Pauline Douglas, Xiaoping Cui, Qi Ding, & Susan P. Lees‐Miller. (2007). trans Autophosphorylation at DNA-Dependent Protein Kinase's Two Major Autophosphorylation Site Clusters Facilitates End Processing but Not End Joining. Molecular and Cellular Biology. 27(10). 3881–3890. 151 indexed citations
19.
Douglas, Pauline, Xiaoping Cui, Wesley D. Block, et al.. (2006). The DNA-Dependent Protein Kinase Catalytic Subunit Is Phosphorylated In Vivo on Threonine 3950, a Highly Conserved Amino Acid in the Protein Kinase Domain. Molecular and Cellular Biology. 27(5). 1581–1591. 105 indexed citations
20.
Ding, Qi. (2002). Research Advances in Gene Therapy. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026